Cargando…
Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?
The BCG vaccine will, in 2021, have been in use for 100 years. Much remains to be understood, including the reasons for its variable efficacy against pulmonary tuberculosis in adults. This review will discuss what has been learnt about the BCG vaccine in the last two decades, and whether this new in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899334/ https://www.ncbi.nlm.nih.gov/pubmed/33583672 http://dx.doi.org/10.1016/j.vaccine.2021.01.068 |